Opioids in mental illness: theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981]
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY
New York Acad. of Sciences
1982
|
| Schriftenreihe: | Annals of the New York Academy of Sciences
398 |
| Schlagworte: | |
| Beschreibung: | XI, 512 S. Ill., graph. Darst. |
| ISBN: | 0897661869 0897661877 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000315452 | ||
| 003 | DE-604 | ||
| 005 | 20150309 | ||
| 007 | t | ||
| 008 | 870612s1982 ad|| |||| 10||| eng d | ||
| 020 | |a 0897661869 |9 0-89766-186-9 | ||
| 020 | |a 0897661877 |9 0-89766-187-7 | ||
| 035 | |a (OCoLC)8929252 | ||
| 035 | |a (DE-599)BVBBV000315452 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-20 |a DE-29 |a DE-188 | ||
| 050 | 0 | |a Q11 | |
| 050 | 0 | |a RC483.5.O64 | |
| 082 | 0 | |a 616.89/18 |2 19 | |
| 082 | 0 | |a 500 |2 19 | |
| 084 | |a MED 970f |2 stub | ||
| 084 | |a MED 610f |2 stub | ||
| 245 | 1 | 0 | |a Opioids in mental illness |b theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] |c ed. by Karl Verebey |
| 264 | 1 | |a New York, NY |b New York Acad. of Sciences |c 1982 | |
| 300 | |a XI, 512 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Annals of the New York Academy of Sciences |v 398 | |
| 650 | 4 | |a Behavior |x drug effects |v Congresses | |
| 650 | 4 | |a Endorphins |x pharmacology |v Congresses | |
| 650 | 4 | |a Mental Disorders |x drug therapy |v Congresses | |
| 650 | 4 | |a Mental illness |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Narcotics |x pharmacology |v Congresses | |
| 650 | 4 | |a Opioids |x Therapeutic use |v Congresses | |
| 650 | 0 | 7 | |a Psychische Störung |0 (DE-588)4047686-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychose |0 (DE-588)4047734-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Endorphine |0 (DE-588)4152186-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakodynamik |0 (DE-588)4174134-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Opiate |0 (DE-588)4075669-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychopharmakologie |0 (DE-588)4176249-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1981 |z New York, NY |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1982 |z New York, NY |2 gnd-content | |
| 689 | 0 | 0 | |a Opiate |0 (DE-588)4075669-5 |D s |
| 689 | 0 | 1 | |a Psychische Störung |0 (DE-588)4047686-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Opiate |0 (DE-588)4075669-5 |D s |
| 689 | 1 | 1 | |a Psychische Störung |0 (DE-588)4047686-8 |D s |
| 689 | 1 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Pharmakodynamik |0 (DE-588)4174134-1 |D s |
| 689 | 2 | 1 | |a Endorphine |0 (DE-588)4152186-9 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Opiate |0 (DE-588)4075669-5 |D s |
| 689 | 3 | 1 | |a Psychose |0 (DE-588)4047734-4 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Opiate |0 (DE-588)4075669-5 |D s |
| 689 | 4 | |5 DE-604 | |
| 689 | 5 | 0 | |a Endorphine |0 (DE-588)4152186-9 |D s |
| 689 | 5 | 1 | |a Psychopharmakologie |0 (DE-588)4176249-6 |D s |
| 689 | 5 | |5 DE-604 | |
| 700 | 1 | |a Verebey, Karl |d 1938- |e Sonstige |0 (DE-588)172437881 |4 oth | |
| 830 | 0 | |a Annals of the New York Academy of Sciences |v 398 |w (DE-604)BV002532608 |9 398 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000193579 | ||
Datensatz im Suchindex
| _version_ | 1804114780369190912 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)172437881 |
| building | Verbundindex |
| bvnumber | BV000315452 |
| callnumber-first | Q - Science |
| callnumber-label | Q11 |
| callnumber-raw | Q11 RC483.5.O64 |
| callnumber-search | Q11 RC483.5.O64 |
| callnumber-sort | Q 211 |
| callnumber-subject | Q - General Science |
| classification_tum | MED 970f MED 610f |
| ctrlnum | (OCoLC)8929252 (DE-599)BVBBV000315452 |
| dewey-full | 616.89/18 500 |
| dewey-hundreds | 600 - Technology (Applied sciences) 500 - Natural sciences and mathematics |
| dewey-ones | 616 - Diseases 500 - Natural sciences and mathematics |
| dewey-raw | 616.89/18 500 |
| dewey-search | 616.89/18 500 |
| dewey-sort | 3616.89 218 |
| dewey-tens | 610 - Medicine and health 500 - Natural sciences and mathematics |
| discipline | Allgemeine Naturwissenschaft Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02977nam a2200757 cb4500</leader><controlfield tag="001">BV000315452</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150309 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1982 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0897661869</subfield><subfield code="9">0-89766-186-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0897661877</subfield><subfield code="9">0-89766-187-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)8929252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000315452</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">Q11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC483.5.O64</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89/18</subfield><subfield code="2">19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">500</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 970f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 610f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Opioids in mental illness</subfield><subfield code="b">theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981]</subfield><subfield code="c">ed. by Karl Verebey</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">New York Acad. of Sciences</subfield><subfield code="c">1982</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 512 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Annals of the New York Academy of Sciences</subfield><subfield code="v">398</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Behavior</subfield><subfield code="x">drug effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endorphins</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental illness</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Narcotics</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Opioids</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychose</subfield><subfield code="0">(DE-588)4047734-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Endorphine</subfield><subfield code="0">(DE-588)4152186-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakodynamik</subfield><subfield code="0">(DE-588)4174134-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakologie</subfield><subfield code="0">(DE-588)4176249-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1981</subfield><subfield code="z">New York, NY</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1982</subfield><subfield code="z">New York, NY</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Pharmakodynamik</subfield><subfield code="0">(DE-588)4174134-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Endorphine</subfield><subfield code="0">(DE-588)4152186-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Psychose</subfield><subfield code="0">(DE-588)4047734-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="5" ind2="0"><subfield code="a">Endorphine</subfield><subfield code="0">(DE-588)4152186-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2="1"><subfield code="a">Psychopharmakologie</subfield><subfield code="0">(DE-588)4176249-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Verebey, Karl</subfield><subfield code="d">1938-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)172437881</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Annals of the New York Academy of Sciences</subfield><subfield code="v">398</subfield><subfield code="w">(DE-604)BV002532608</subfield><subfield code="9">398</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000193579</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1981 New York, NY gnd-content (DE-588)1071861417 Konferenzschrift 1982 New York, NY gnd-content |
| genre_facet | Konferenzschrift 1981 New York, NY Konferenzschrift 1982 New York, NY |
| id | DE-604.BV000315452 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:12:09Z |
| institution | BVB |
| isbn | 0897661869 0897661877 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000193579 |
| oclc_num | 8929252 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-20 DE-29 DE-188 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-20 DE-29 DE-188 |
| physical | XI, 512 S. Ill., graph. Darst. |
| publishDate | 1982 |
| publishDateSearch | 1982 |
| publishDateSort | 1982 |
| publisher | New York Acad. of Sciences |
| record_format | marc |
| series | Annals of the New York Academy of Sciences |
| series2 | Annals of the New York Academy of Sciences |
| spelling | Opioids in mental illness theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] ed. by Karl Verebey New York, NY New York Acad. of Sciences 1982 XI, 512 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Annals of the New York Academy of Sciences 398 Behavior drug effects Congresses Endorphins pharmacology Congresses Mental Disorders drug therapy Congresses Mental illness Chemotherapy Congresses Narcotics pharmacology Congresses Opioids Therapeutic use Congresses Psychische Störung (DE-588)4047686-8 gnd rswk-swf Psychose (DE-588)4047734-4 gnd rswk-swf Endorphine (DE-588)4152186-9 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Pharmakodynamik (DE-588)4174134-1 gnd rswk-swf Opiate (DE-588)4075669-5 gnd rswk-swf Psychopharmakologie (DE-588)4176249-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1981 New York, NY gnd-content (DE-588)1071861417 Konferenzschrift 1982 New York, NY gnd-content Opiate (DE-588)4075669-5 s Psychische Störung (DE-588)4047686-8 s DE-604 Pharmakotherapie (DE-588)4076066-2 s Pharmakodynamik (DE-588)4174134-1 s Endorphine (DE-588)4152186-9 s Psychose (DE-588)4047734-4 s Psychopharmakologie (DE-588)4176249-6 s Verebey, Karl 1938- Sonstige (DE-588)172437881 oth Annals of the New York Academy of Sciences 398 (DE-604)BV002532608 398 |
| spellingShingle | Opioids in mental illness theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] Annals of the New York Academy of Sciences Behavior drug effects Congresses Endorphins pharmacology Congresses Mental Disorders drug therapy Congresses Mental illness Chemotherapy Congresses Narcotics pharmacology Congresses Opioids Therapeutic use Congresses Psychische Störung (DE-588)4047686-8 gnd Psychose (DE-588)4047734-4 gnd Endorphine (DE-588)4152186-9 gnd Pharmakotherapie (DE-588)4076066-2 gnd Pharmakodynamik (DE-588)4174134-1 gnd Opiate (DE-588)4075669-5 gnd Psychopharmakologie (DE-588)4176249-6 gnd |
| subject_GND | (DE-588)4047686-8 (DE-588)4047734-4 (DE-588)4152186-9 (DE-588)4076066-2 (DE-588)4174134-1 (DE-588)4075669-5 (DE-588)4176249-6 (DE-588)1071861417 |
| title | Opioids in mental illness theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] |
| title_auth | Opioids in mental illness theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] |
| title_exact_search | Opioids in mental illness theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] |
| title_full | Opioids in mental illness theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] ed. by Karl Verebey |
| title_fullStr | Opioids in mental illness theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] ed. by Karl Verebey |
| title_full_unstemmed | Opioids in mental illness theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] ed. by Karl Verebey |
| title_short | Opioids in mental illness |
| title_sort | opioids in mental illness theories clinical observations and treatment possibilities results of a conference held by the new york academy of sciences oct 28 30 1981 |
| title_sub | theories, clinical observations, and treatment possibilities ; [results of a conference held by the New York Academy of Sciences, Oct. 28 - 30, 1981] |
| topic | Behavior drug effects Congresses Endorphins pharmacology Congresses Mental Disorders drug therapy Congresses Mental illness Chemotherapy Congresses Narcotics pharmacology Congresses Opioids Therapeutic use Congresses Psychische Störung (DE-588)4047686-8 gnd Psychose (DE-588)4047734-4 gnd Endorphine (DE-588)4152186-9 gnd Pharmakotherapie (DE-588)4076066-2 gnd Pharmakodynamik (DE-588)4174134-1 gnd Opiate (DE-588)4075669-5 gnd Psychopharmakologie (DE-588)4176249-6 gnd |
| topic_facet | Behavior drug effects Congresses Endorphins pharmacology Congresses Mental Disorders drug therapy Congresses Mental illness Chemotherapy Congresses Narcotics pharmacology Congresses Opioids Therapeutic use Congresses Psychische Störung Psychose Endorphine Pharmakotherapie Pharmakodynamik Opiate Psychopharmakologie Konferenzschrift 1981 New York, NY Konferenzschrift 1982 New York, NY |
| volume_link | (DE-604)BV002532608 |
| work_keys_str_mv | AT verebeykarl opioidsinmentalillnesstheoriesclinicalobservationsandtreatmentpossibilitiesresultsofaconferenceheldbythenewyorkacademyofsciencesoct28301981 |